The FDA approves remibrutinib for symptomatic dermographism, the first such therapy, extending an oral BTK inhibitor label via the Phase III RemIND trial.
News|Articles|November 24, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-12-02-2015
- Volume 11
- Issue 12
Shimadzu’s Nexera UC Wins R&D 100 Award
Author(s)Pharmaceutical Technology Editors
The Nexera UC Unified Chromatography System from Shimadzu Scientific Instruments was recognized with an R&D100 award.
Shimadzu Scientific Intstruments has announced that its Nexera UC Unified Chromatography system had received an R&D magazine 100 Award, from R&D magazine identifying the system as one of the most technically significant new products of the year in the analytical and testing category.
The Nexera UC system combines supercritical fluidic extraction with supercritical fluid chromatography, eliminates the need for sample pre-treatment, and reduces the possibility of human error during analysis, the company reported in a Nov. 23, 2015 announcement.
According to the magazine, the Nexera UC takes five minutes to analyze pesticides in food and has a high target analyte recovery rate.
In selecting the Nexera UC for the award, R&D magazine reported that the system’s automated technology opens up new analytical opportunities in many fields, including drug discovery and delivery, chemicals, pharmaceuticals, and cleaning validation.
Source:
Articles in this issue
almost 11 years ago
Software Corrects Spectra Dataalmost 11 years ago
Lab Reactor Designed for Scale-upalmost 11 years ago
Instrument Measures Endotoxins at Point of Usealmost 11 years ago
Instrument Manufacturers Collaborate on Interoperabilityalmost 11 years ago
HTS Reader Features Three Light Sourcesalmost 11 years ago
“A Hit for Every Target” and Changing the Model for Pharma Innovationalmost 11 years ago
Researchers Identify Advances for Heterocyclic Chemistryalmost 11 years ago
CMOs Lead Ongoing Drive for Single-Use Adoptionalmost 11 years ago
System Automates Traceabilityalmost 11 years ago
Lufthansa Cargo Offers CSafe ContainersRelated to this article
The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.